These are rare but underscore that MT-II carries real medical risks
Not intended to diagnose, treat, cure or prevent any disease
The FDA has approved three medications specifically for weight loss as of my preparation of this content: liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) (National Institute of Diabetes and Digestive and Kidney Diseases, 2026b)
But heres the catchhepcidin, the iron-regulating hormone in the liver, plays a role as a watchful bouncer, inhibiting ferroportin under inflammation or when iron is high to avoid overloading
Its primary pharmacological characterization was published in European Journal of Endocrinology (PMID 9849822), where the authors identified it as the first growth-hormone-secretagogue receptor (GHSR-1a) agonist achieving GH-release selectivity comparable to GHRH in animal models